Css LLC Moderna, Inc. Put Options Transaction History

Css LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $979,981 - $1.61 Million	-8,300 Reduced 45.36%	10,000 $1.18 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $1.08 Million - $1.62 Million	-9,200 Reduced 33.45%	18,300 $2.61 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $1.15 Million - $2.14 Million	-9,100 Reduced 24.86%	27,500 $4.74 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $3.05 Million - $4.97 Million	13,500 Added 58.44%	36,600 $9.3 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $1.55 Million - $3.39 Million	-7,000 Reduced 23.26%	23,100 $8.89 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $1.31 Million - $2.37 Million	10,100 Added 50.5%	30,100 $7.07 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $3.92 Million - $6.68 Million	-35,900 Reduced 64.22%	20,000 $2.62 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $1.21 Million - $3.13 Million	18,400 Added 49.07%	55,900 $5.84 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $5.09 Million - $8.89 Million	-93,700 Reduced 71.42%	37,500 $2.65 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $3.89 Million - $10.5 Million	131,200 New	131,200 $8.42 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.